PerCP/Cyanine5.5 anti-mouse Ly-6C Antibody
- 产品名称:
- PerCP/Cyanine5.5 anti-mouse Ly-6C Antibody
- 产品类别:
- 抗体
- 产品编号:
- 128011
- 产品应用:
- 128011
- Verified Reactivity
- Mouse
- Antibody Type
- Monoclonal
- Host Species
- Rat
- Immunogen
- L3 cloned CTL cells
- Formulation
- Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
- Preparation
- The antibody was purified by affinity chromatography, and conjugated with PerCP/Cyanine5.5 under optimal conditions.
- Concentration
- 0.2 mg/ml
- Storage & Handling
- The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
- Application
-
FC - Quality tested
- Recommended Usage
Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 ?g per 106 cells in 100 ?l volume. It is recommended that the reagent be titrated for optimal performance for each application.
* PerCP/Cyanine5.5 has a maximum absorption of 482 nm and a maximum emission of 690 nm.
- Application Notes
Clone HK1.4 does not block the binding of clone RB6-8C58.
Additional reported applications (for relevant formats of this clone) include: in vitro activation of T cells1-3 and immunohistochemistry of frozen sections4.
- Additional Product Notes
- BioLegend is in the process of converting the name PerCP/Cy5.5 to PerCP/Cyanine5.5. The dye molecule remains the same, so you should expect the same quality and performance from our PerCP/Cyanine5.5 products. Contact Technical Service if you have any questions.
- Application References
(PubMed link indicates BioLegend citation) -
- Jutila MA, et al. 1988. Eur. J. Immunol. 18:1819. (Activ)
- Herold KC, et al. 1990. Diabetes 39:815. (Activ)
- Havran WL, et al. 1988. J. Immunol. 140:1034 (Activ)
- Flanagan K, et al. 2008. J. Immunol. 180:3874. (IHC)
- Makaroff LE, et al. 2009. P. Natl. Acad. Sci. USA 106:4799. (FC)
- Zuber J, et al. 2009. Genes Dev. 23:877. (FC) PubMed
- Ribechini E, et al. 2009. Eur. J. Immunol. 39:3538.
- Ma C, et al. 2012. J. Leukoc. Biol. 92:1199.
- Watson NB, et al. 2015. J Immunol. 194:2796. PubMed
- Product Citations
-
- Marchelletta RR, et al. 2021. J Clin Invest. 131:. PubMed
- Xiang G, et al. 2022. Cell Death Dis. 13:451. PubMed
- Sch?dlich IS, et al. 2022. iScience. 25:104470. PubMed
- Hutter K, et al. 2022. Front Immunol. 13:967914. PubMed
- Ballesteros I, et al. 2014. J Vis Exp. 94: 52031. PubMed
- Gallizioli M, et al. 2020. Cell Rep. 33:108291. PubMed
- Lin C et al. 2019. Immunity. 50(1):137-151 . PubMed
- Turecamo SE, et al. 2018. Matrix Biol. 67:01:00. PubMed
- Yu X, et al. 2020. Nat Commun. 11:1110. PubMed
- Jong RM, et al. 2022. J Immunol. 208:407. PubMed
- Tang L, et al. 2021. Oncol Lett. 22:605. PubMed
- Israelow B, et al. 2020. bioRxiv. . PubMed
- Gonalves S, et al. 2021. Cell Reports. 34(11):108860. PubMed
- Fachi JL et al. 2019. Cell reports. 27(3):750-761 . PubMed
- Song J, et al. 2021. J Am Heart Assoc. 10:e017329. PubMed
- Xu ZH, et al. 2021. Mediators Inflamm. 2021:8856326. PubMed
- Mylonas K, et al. 2015. Immunobiology. 220: 924-933. PubMed
- Leach SM, et al. 2020. Cell Rep. 33:108337. PubMed
- Yilmaz B, et al. 2021. Cell Host Microbe. 29(4):650-663.e9. PubMed
- Zhang K, et al. 2018. PLoS Pathog. 14:e1006925. PubMed
- Huard A, et al. 2021. J Immunol. 206:1058. PubMed
- Demars A, et al. 2021. PLoS Pathog. 17:e1009887. PubMed
- Yang Y, et al. 2020. Cell Death Discov. 0.293055556. PubMed
- Park JA, et al. 2021. J Hematol Oncol. 14:142. PubMed
- Rao S, et al. 2017. Cell. 168(3):503-516.e12. PubMed
- Shemer A, et al. 2020. Immunity. 53(5):1033-1049.e7. PubMed
- Di Gioia M, et al. 2020. Nat Immunol. 21:42. PubMed
- Han YH, et al. 2021. Science. 373:. PubMed
- Ellis G, et al. 2015. EMBO Rep. 16: 1203-1218. PubMed
- Zhou Z, et al. 2019. Oxid Med Cell Longev. 2019:1209307. PubMed
- Zhang Y, et al. 2015. PLoS Pathog. 11: e1005167. PubMed
- Stutchfield B, et al. 2015. Gastroenterology. 149: 1896-1909.e14. PubMed
- Jeljeli M, et al. 2020. Cell Rep. 33:108325. PubMed
- McCreedy DA et al. 2018. eNeuro. 5(4) pii: ENEURO. PubMed
- Forbester JL, et al. 2020. J Virol. 94:. PubMed
- Cassidy BR, et al. 2020. J Neuroinflammation. 17:259. PubMed
- Honarpisheh P, et al. 2020. J Neuroinflammation. 0.9625. PubMed
- Tanaka T, et al. 2015. J Immunol. 194:2004. PubMed
- Lagares D, et al. 2017. Sci Transl Med. 9:eaal3765. PubMed
- Varol D et al. 2017. Immunity. 46(6):1030-1044 . PubMed
- Horn KJ, et al. 2022. Nat Commun. 13:3321. PubMed
- Okubo K, et al. 2021. Cell Reports. 35(7):109142. PubMed
- Doonan J, et al. 2019. Nat Commun. 10:1554. PubMed
- Harnett MM, et al. 2022. Front Immunol. 13:953053. PubMed
- Golden TN, et al. 2022. Front Pharmacol. 12:761496. PubMed
- Panea C, et al. 2021. Commun Biol. 4:913. PubMed
- Brigas HC, et al. 2021. Cell Reports. 36(9):109574. PubMed
- Paiva-Oliveira E, et al. 2017. Histochem Cell Biol. 10.1007/s00418-017-1556-6. PubMed
- Qi S et al. 2016. eLife. 5 pii: e14756. PubMed
- Engler AE, et al. 2020. Cell Reports. 33(13):108553. PubMed
- Zeng W, et al. 2021. STAR Protocols. 2(1):100361. PubMed
- Medler TR et al. 2018. Cancer cell. 34(4):561-578 . PubMed
- Tang C, et al. 2021. Theranostics. 11:9791. PubMed
- Rashid MH, et al. 2021. Oncol Rep. 45:1171. PubMed
- Blriot C, et al. 2021. Immunity. :. PubMed
- Ermert D, et al. 2016. PLoS Pathog. 11: 1005043. PubMed
- Jamali A, et al. 2020. Cell Reports. 32(9):108099. PubMed
- Williams JW, et al. 2017. Circ Res. 121:662. PubMed
- Landon J Edgar et al. 2018. Cell chemical biology. 26(1):131-136 . PubMed
- Yang Y, et al. 2020. Cell Death Discov. 6:62. PubMed
- Wuggenig P, et al. 2020. Commun Biol. 3:130. PubMed
- Ali S, et al. 2021. PLoS One. 16:e0246646. PubMed
- Nuro-Gyina PK, et al. 2021. J Immunol. 207:868. PubMed
- Ioannidis L, et al. 2016. J Immunol. 196: 1227 - 1238. PubMed
- Matsumura T, et al. 2022. Nat Commun. 13:7064. PubMed
- Hadas R, et al. 2020. JCI Insight. 5:00. PubMed
- Teo T, et al. 2015. J Virol. 89: 7955-7969. PubMed
- Dahlgren MW et al. 2019. Immunity. 50(3):707-722 . PubMed
- Pinho–Ribeiro FA, et al. 2018. Cell. 173:1083. PubMed
- Budai Z, et al. 2021. Cells. 10:. PubMed
- Fontana MF, et al. 2015. Parasite Immunol. 37: 470-478. PubMed
- Jiang L, et al. 2020. Cell. 183(5):1219-1233.e18. PubMed
- Kumari P, et al. 2021. Cell Reports. 35(3):109012. PubMed
- Klein O, et al. 2019. J Allergy Clin Immunol. 144:1074. PubMed
- Canedo T, et al. 2021. Neuropsychopharmacology. 46:2358. PubMed
- Nishio H, et al. 2020. Regen Ther. 14:262. PubMed
- Rustenhoven J, et al. 2021. Cell. 184(4):1000-1016.e27. PubMed
- Huo M, et al. 2017. FASEB J. 10.1096/fj.201601030R. PubMed
- Namkoong H, et al. 2018. PLoS Pathog. 14:e1006955. PubMed
- Zhu YP et al. 2018. Cell reports. 24(9):2329-2341 . PubMed
- Foster G, et al. 2015. J Immunol. 195: 5380 - 5392. PubMed
- Yajjala V, et al. 2016. J Immunol. 196: 4196 - 4203. PubMed
- Yin X, et al. 2020. Cell Rep. 33:108278. PubMed
- Hendrikx S et al. 2019. Cell reports. 26(5):1227-1241 . PubMed
- Walsh CM, et al. 2019. Elife. 8:e48448. PubMed
- Lei Y, et al. 2021. Sci Adv. 7:. PubMed
- Chen X, et al. 2021. Cell Death Dis. 12:1123. PubMed
- Freed-Pastor WA, et al. 2021. Cancer Cell. :. PubMed
- Heuslein J, et al. 2016. Sci Rep. 6: 27029. PubMed
- Jiang Y, et al. 2015. MBio. 6: e01426-15. PubMed
- Al-Zaeed N, et al. 2021. Cell Death Dis. 12:611. PubMed
- Gangoso E, et al. 2021. Cell. 184:2454. PubMed
- Ikezu S, et al. 2021. Mol Psychiatry. 26:1808. PubMed
- Awida Z, et al. 2021. Int J Mol Sci. 23:. PubMed
- Tran S, et al. 2020. Immunity. 53(3):627-640.e5. PubMed
- Valdearcos M et al. 2017. Cell metabolism. 26(1):185-197 . PubMed
- Orr MT, et al. 2019. NPJ Vaccines. 4:1. PubMed
- Sadtler K, et al. 2017. Tissue Eng Part A. 23:1044. PubMed
- Ioanna E Galani et al. 2017. Immunity. 46(5):875-890 . PubMed
- Boguslawski KM, et al. 2020. Sci Adv. 6:eaax7515. PubMed
- Joshi JC, et al. 2020. Cell Rep. 30:4096. PubMed
- Avgustinova A, et al. 2021. Cell Stem Cell. . PubMed
- Steinmetz O, et al. 2016. J Infect Dis. 10.1093/infdis/jiv763. PubMed
- Qi S, et al. 2020. Theranostics. 10:1814. PubMed
- Deniset JF et al. 2019. Immunity. 51(1):131-140 . PubMed
- Yá?ez A et al. 2017. Immunity. 47(5):890-902 . PubMed
- RRID
- AB_1659242 (BioLegend Cat. No. 128011) AB_1659241 (BioLegend Cat. No. 128012)
- Structure
- 14-17 kD protein (134 amino acids), member of the Ly-6 family of GPI linked protein. Ly6 family members share structure homology throughout a distinctive cystein rich protein domain that incorporates O-linked carbohydrates.
- Distribution
-
Ly-6C is expressed primarily on bone marrow myeloid populations, monocytes/macrophages, neutrophils, endothelial cells, and some T cell subsets. Ly-6C is also a marker of memory CD8+ T cells.
- Cell Type
- Endothelial cells, Macrophages, Monocytes, Neutrophils, T cells
- Biology Area
- Immunology
- Molecular Family
- CD Molecules
- Antigen References
-
1. Jutila MA, et al. 1988. Eur. J. Immunol. 18:1819.
2. Cerwenka A, et al. 1998. J. Immunol. 161:97.
- Gene ID
- 17067 View all products for this Gene ID
- UniProt
- View information about Ly-6C on UniProt.org